3rd Quarter - Report
OGR for TAKEDA PHARMACEUTICALS AMERICA INC
Firm
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part D and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN New | COSRepConfCOS/DCOS/LDHensarlingDirGramm |
| ALISSA CLEES | — |
| CHRIS GIBLIN New | COS, Cong. Carter; LD, Norwood; LA, Fields |
| CONRAD LASS New | SpcAsst/COS, BLM;LA,Thomas;Asst,Simpson |
| MOSES MERCADO | — |
| GORDON TAYLOR | — |
Health Issues HCR
Issues related to the implementation of the Patient Protection and Affordable Care Act (Public Law No: 111-148), the pharmaceutical industry, diabetes care, obesity and mental health. H.R.2415/S.1184, Treat and Reduce Obesity Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN New | COSRepConfCOS/DCOS/LDHensarlingDirGramm |
| ALISSA CLEES | — |
| CHRIS GIBLIN New | COS, Cong. Carter; LD, Norwood; LA, Fields |
| CONRAD LASS New | SpcAsst/COS, BLM;LA,Thomas;Asst,Simpson |
| MOSES MERCADO | — |
| GORDON TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.